OFAC Sanctions Chinese Chemical Company and Its Associates in Synthetic Opioid Crackdown

TL;DR

  • OFAC sanctioned China-based chemical company Guangzhou Tengyue Chemical Co., Ltd. and two individuals for trafficking synthetic opioids and cutting agents to the United States.
  • The designation includes one Bitcoin address linked to company representative Huang Xiaojun, who coordinated illicit drug shipments to the US.
  • This action is part of a joint effort with the DEA and FBI to combat the trafficking of synthetic drugs, as well as dangerous analgesic chemicals often used as cutting agents.

Today, the U.S. Department of the Treasury’s Office of Foreign Assets Control (OFAC), in coordination with the Drug Enforcement Administration (DEA) and the Federal Bureau of Investigation (FBI), sanctioned the China-based chemical company Guangzhou Tengyue Chemical Co., Ltd. (Guangzhou Tengyue), along with two of its associates for synthetic opioid trafficking. A crypto address was included for Huang Xiaojun, a Chinese national who attempted to sell controlled substances on behalf of Guangzhou Tengyue to a U.S. buyer in 2023.

According to OFAC, the designated entity specifically dealt in nitazenes, synthetic substances that can cause respiratory failure and are trafficked and abused for their opioid-like effects. Guangzhou Tengyue also advertised the sale of xylazine (known as “tranq”), a veterinary sedative used as a cutting agent that is particularly dangerous because it does not respond to Narcan, the standard overdose reversal treatment. Despite these risks, Guangzhou Tengyue actively marketed these substances and assured buyers their packages would clear U.S. customs.

Guangzhou Tengyue’s on-chain activity

The crypto address included for Xiaojun was used in Guangzhou Tengyue’s attempt to sell a controlled substance to a U.S. buyer in 2023. As shown in the Reactor graph below, payments were also made to this address by crypto ATMs and darknet market vendors. Xiaojun’s address received $1.26 million between January 2021 and January 2025.

Strategic implications

Today’s action demonstrates the U.S. government’s continued focus on disrupting the financial infrastructure supporting international drug trafficking operations, including cryptocurrency payment channels. By designating specific cryptocurrency addresses, OFAC provides concrete operational intelligence that helps cryptocurrency businesses identify and prevent transactions with drug trafficking operations.

We have labeled the above Bitcoin address in our product suite and will continue monitoring for additional addresses and entities connected to synthetic opioid trafficking operations.

This website contains links to third-party sites that are not under the control of Chainalysis, Inc. or its affiliates (collectively “Chainalysis”). Access to such information does not imply association with, endorsement of, approval of, or recommendation by Chainalysis of the site or its operators, and Chainalysis is not responsible for the products, services, or other content hosted therein. 

This material is for informational purposes only, and is not intended to provide legal, tax, financial, or investment advice. Recipients should consult their own advisors before making these types of decisions. Chainalysis has no responsibility or liability for any decision made or any other acts or omissions in connection with Recipient’s use of this material.

Chainalysis does not guarantee or warrant the accuracy, completeness, timeliness, suitability or validity of the information in this report and will not be responsible for any claim attributable to errors, omissions, or other inaccuracies of any part of such material.

The post OFAC Sanctions Chinese Chemical Company and Its Associates in Synthetic Opioid Crackdown appeared first on Chainalysis.

Source
Disclaimer: The content above is only the author's opinion which does not represent any position of Followin, and is not intended as, and shall not be understood or construed as, investment advice from Followin.
Like
Add to Favorites
Comments